Last update 21 Nov 2024
Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Probiotics |
Synonyms Combined Bifidobacterium ,Lactobacillus,Enterococcus and Bacillus, 双歧杆菌四联活菌（杭州远大生物制药）, 思连康 |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (02 Mar 2006), |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)双歧杆菌四联活菌片（思连康）治疗儿童急性腹泻的多中心、随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial of Bifidobacterium tetravalent live bacteria tablets (Siliankang) in the treatment of acute diarrhea in children
双歧杆菌四联活菌片(思连康)治疗妊娠期便秘的Ⅱ/Ⅲ期无缝设计、多中心、随机、双盲、安慰剂对照临床试验
[Translation] Phase II/III seamless design, multicenter, randomized, double-blind, placebo-controlled clinical trial of Bifidobacterium tetravalent viable tablets (Siliankang) for the treatment of constipation during pregnancy
Clinical Study on Bifidobacterium Quadruple Live Bacteria Tablets (Si Lian Kang) Reducing the Incidence Rate of Adverse Reactions in Helicobacter Pylori Quadruple Eradication Therapy and on the Effects of Gastrointestinal Flora
100 Clinical Results associated with Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)
Login to view more data
100 Translational Medicine associated with Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)
Login to view more data
100 Patents (Medical) associated with Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)
Login to view more data
100 Deals associated with Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (Grand Biologic)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Constipation | CN | 02 Mar 2006 | |
| Diarrhea | CN | 02 Mar 2006 | |
| Dyspepsia | CN | 02 Mar 2006 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute diarrhea | Phase 2 | CN | 07 Mar 2024 | |
| Constipation - functional | Phase 1 | CN | 31 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free